Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.18 - $0.86 $3,857 - $18,428
-21,428 Reduced 49.83%
21,572 $6,000
Q1 2022

May 11, 2022

SELL
$0.6 - $1.06 $174 - $308
-291 Reduced 0.67%
43,000 $26,000
Q4 2021

Feb 08, 2022

SELL
$0.85 - $1.4 $850 - $1,400
-1,000 Reduced 2.26%
43,291 $39,000
Q3 2021

Nov 02, 2021

BUY
$1.33 - $1.77 $3,724 - $4,956
2,800 Added 6.75%
44,291 $59,000
Q2 2021

Aug 11, 2021

BUY
$1.41 - $1.94 $58,502 - $80,492
41,491 New
41,491 $60,000
Q3 2020

Nov 04, 2020

SELL
$1.91 - $3.08 $19,942 - $32,158
-10,441 Closed
0 $0
Q2 2020

Jul 17, 2020

BUY
$1.97 - $3.98 $20,568 - $41,555
10,441 New
10,441 $29,000
Q1 2019

May 06, 2019

SELL
$1.39 - $1.71 $18,070 - $22,230
-13,000 Closed
0 $0
Q2 2017

Aug 15, 2017

BUY
N/A
13,000
13,000 $20,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.